Quantum Biopharma (QNTM) Payables (2018 - 2026)

Quantum Biopharma has disclosed Payables across 9 years of filings, most recently posting $300549.0 for Q1 2026.

• Payables for Q1 2026 came in at $300549.0, down 72.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $300549.0 (down 72.37% YoY), and the FY2025 annual result was $3.3 million, down 15.27% from the prior year.
• Payables came in at $300549.0 for Q1 2026 at Quantum Biopharma, down from $3.3 million in the prior quarter.
• In the past five years, Payables ranged from a high of $7.4 million in Q4 2022 to a low of $300549.0 in Q1 2022.
• The 5-year median for Payables is $458055.5 (2022), against an average of $1.7 million.
• Across the five-year window, Payables jumped 557.23% in 2025 and sank 72.37% in 2026, its largest moves.
• Quantum Biopharma's Payables stood at $7.4 million in 2022, then plunged by 43.38% to $4.2 million in 2023, then fell by 7.66% to $3.9 million in 2024, then dropped by 15.27% to $3.3 million in 2025, then tumbled by 90.84% to $300549.0 in 2026.
• The last three Payables figures came in at $300549.0 (Q1 2026), $3.3 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.